MS vs NMR
Morgan Stanley and Nomura Holdings, Inc., both Financial Services
Morgan Stanley is the larger company at $352B against $26B. Over the past year NMR returned +29% against +21% for MS.
| Figure | MS | NMR |
|---|---|---|
| Last close | $190 | $9.60 |
| Market cap | $352B | $26B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 15.4 | n/a |
| Dividend yield | 2.1% | n/a |
| 1-year return | +21% | +29% |
| 5-year return | +112% | +99% |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Morgan Stanley
Revenue of $21B in Q2 2026, net income $5.6B.
Nomura Holdings, Inc.
Revenue of $2.4T in H2 2026, net income $165B.
Open these two in the interactive comparison to add more names, change the period or see the correlation.